Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 8807

1.

RNA sequencing reveals upregulation of a transcriptomic program associated with stemness in metastatic prostate cancer cells selected for taxane resistance.

Cajigas-Du Ross CK, Martinez SR, Woods-Burnham L, Durán AM, Roy S, Basu A, Ramirez JA, Ortiz-Hernández GL, Ríos-Colón L, Chirshev E, Sanchez-Hernandez ES, Soto U, Greco C, Boucheix C, Chen X, Unternaehrer J, Wang C, Casiano CA.

Oncotarget. 2018 Jul 13;9(54):30363-30384. doi: 10.18632/oncotarget.25744. eCollection 2018 Jul 13.

2.

Effects of miRNAs on functions of breast cancer stem cells and treatment of breast cancer.

Zhang Y, Xu B, Zhang XP.

Onco Targets Ther. 2018 Jul 24;11:4263-4270. doi: 10.2147/OTT.S165156. eCollection 2018. Review.

3.

Programmed cell removal by calreticulin in tissue homeostasis and cancer.

Feng M, Marjon KD, Zhu F, Weissman-Tsukamoto R, Levett A, Sullivan K, Kao KS, Markovic M, Bump PA, Jackson HM, Choi TS, Chen J, Banuelos AM, Liu J, Gip P, Cheng L, Wang D, Weissman IL.

Nat Commun. 2018 Aug 10;9(1):3194. doi: 10.1038/s41467-018-05211-7.

4.

The SUMO System and TGFβ Signaling Interplay in Regulation of Epithelial-Mesenchymal Transition: Implications for Cancer Progression.

Chanda A, Sarkar A, Bonni S.

Cancers (Basel). 2018 Aug 8;10(8). pii: E264. doi: 10.3390/cancers10080264. Review.

5.

Sonic Hedgehog Medulloblastoma Cancer Stem Cells Mirnome and Transcriptome Highlight Novel Functional Networks.

Po A, Abballe L, Sabato C, Gianno F, Chiacchiarini M, Catanzaro G, De Smaele E, Giangaspero F, Ferretti E, Miele E, Besharat ZM.

Int J Mol Sci. 2018 Aug 8;19(8). pii: E2326. doi: 10.3390/ijms19082326.

6.

MicroRNA regulation of liver cancer stem cells.

Lou W, Liu J, Gao Y, Zhong G, Ding B, Xu L, Fan W.

Am J Cancer Res. 2018 Jul 1;8(7):1126-1141. eCollection 2018. Review.

7.

Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor.

Kuo KT, Huang WC, Bamodu OA, Lee WH, Wang CH, Hsiao M, Wang LS, Yeh CT.

Clin Epigenetics. 2018 Aug 9;10(1):107. doi: 10.1186/s13148-018-0533-9.

8.

Dietary phytochemicals in breast cancer research: anticancer effects and potential utility for effective chemoprevention.

Kapinova A, Kubatka P, Golubnitschaja O, Kello M, Zubor P, Solar P, Pec M.

Environ Health Prev Med. 2018 Aug 9;23(1):36. doi: 10.1186/s12199-018-0724-1.

9.

ALDH1A3 Is the Key Isoform That Contributes to Aldehyde Dehydrogenase Activity and Affects in Vitro Proliferation in Cardiac Atrial Appendage Progenitor Cells.

Puttini S, Plaisance I, Barile L, Cervio E, Milano G, Marcato P, Pedrazzini T, Vassalli G.

Front Cardiovasc Med. 2018 Jul 24;5:90. doi: 10.3389/fcvm.2018.00090. eCollection 2018.

10.

Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?

Sosa Iglesias V, Giuranno L, Dubois LJ, Theys J, Vooijs M.

Front Oncol. 2018 Jul 24;8:267. doi: 10.3389/fonc.2018.00267. eCollection 2018. Review.

11.

Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.

Ren J, Ding L, Zhang D, Shi G, Xu Q, Shen S, Wang Y, Wang T, Hou Y.

Theranostics. 2018 Jun 24;8(14):3932-3948. doi: 10.7150/thno.25541. eCollection 2018.

12.

Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma.

Wu CX, Wang XQ, Chok SH, Man K, Tsang SHY, Chan ACY, Ma KW, Xia W, Cheung TT.

Theranostics. 2018 Jun 13;8(14):3737-3750. doi: 10.7150/thno.25487. eCollection 2018.

13.

Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas.

Rasti A, Mehrazma M, Madjd Z, Abolhasani M, Saeednejad Zanjani L, Asgari M.

Sci Rep. 2018 Aug 6;8(1):11739. doi: 10.1038/s41598-018-30168-4.

14.

DBC1 regulates Wnt/β-catenin-mediated expression of MACC1, a key regulator of cancer progression, in colon cancer.

Kim HJ, Moon SJ, Kim SH, Heo K, Kim JH.

Cell Death Dis. 2018 Aug 6;9(8):831. doi: 10.1038/s41419-018-0899-9.

15.

Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis.

Buccarelli M, Marconi M, Pacioni S, De Pasqualis I, D'Alessandris QG, Martini M, Ascione B, Malorni W, Larocca LM, Pallini R, Ricci-Vitiani L, Matarrese P.

Cell Death Dis. 2018 Aug 6;9(8):841. doi: 10.1038/s41419-018-0864-7.

16.

Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma.

Pandit H, Li Y, Li X, Zhang W, Li S, Martin RCG.

BMC Cancer. 2018 Aug 3;18(1):783. doi: 10.1186/s12885-018-4683-0.

17.

HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell properties.

Abel EV, Goto M, Magnuson B, Abraham S, Ramanathan N, Hotaling E, Alaniz AA, Kumar-Sinha C, Dziubinski ML, Urs S, Wang L, Shi J, Waghray M, Ljungman M, Crawford HC, Simeone DM.

Elife. 2018 Aug 3;7. pii: e33947. doi: 10.7554/eLife.33947. [Epub ahead of print]

18.

Stem-Like Signature Predicting Disease Progression in Early Stage Bladder Cancer. The Role of E2F3 and SOX4.

Bellmunt J.

Biomedicines. 2018 Aug 2;6(3). pii: E85. doi: 10.3390/biomedicines6030085. Review.

19.

Stroma-derived IL-6, G-CSF and Activin-A mediated dedifferentiation of lung carcinoma cells into cancer stem cells.

Rodrigues CFD, Serrano E, Patrício MI, Val MM, Albuquerque P, Fonseca J, Gomes CMF, Abrunhosa AJ, Paiva A, Carvalho L, Botelho MF, Almeida L, Carreira IM, Alpoim MC.

Sci Rep. 2018 Aug 1;8(1):11573. doi: 10.1038/s41598-018-29947-w.

20.

STAT3 exacerbates survival of cancer stem-like tumorspheres in EGFR-positive colorectal cancers: RNAseq analysis and therapeutic screening.

Cheng CC, Liao PN, Ho AS, Lim KH, Chang J, Su YW, Chen CG, Chiang YW, Yang BL, Lin HC, Chang YC, Chang CC, Chang YF.

J Biomed Sci. 2018 Aug 2;25(1):60. doi: 10.1186/s12929-018-0456-y.

Supplemental Content

Loading ...
Support Center